AJKD this month has an extended editorial section on the KDOQI guidelines for CKD. It is now 10 years since these guidelines were introduced and their impact on nephrology has been significant, not least due to the fact that many more patients are now recognized as having early CKD that may have been missed in the past. These patients with moderately reduced GFRs, while unlikely to progress to ESRD, still have a significantly increased risk of cardiovascular morbidity and mortality.
The articles comprise a series of commentaries written by members of the editorial board of AJKD and examine the impact of these guidelines on the NKF itself, research, primary care, clinical laboratories (which now routinely report eGFRs) and the practice of nephrology around the world.
0 comments:
Post a Comment